Monitoring Chemotherapy Response in Small-Cell Lung Cancer Patients
Author Information
Author(s): Pelosi G, Pasini F, Ottensmeier C, Pavanel F, Bresaola E, Bonetti A, Fraggetta F, Terzi A, Iannucci A, Cetto G L
Primary Institution: European Institute of Oncology
Hypothesis
The study evaluates the efficacy of chemotherapy in purging bone marrow and its relationship with survival in small-cell lung cancer patients.
Conclusion
Chemotherapy is not effective in purging bone marrow, even in patients who respond to treatment.
Supporting Evidence
- Marrow contamination was associated with lower survival.
- Marrow involvement was an independent factor of unfavourable prognosis.
- Only 25% of initially positive responders had negative bone marrow after chemotherapy.
Takeaway
The study found that chemotherapy doesn't clean out cancer cells from the bone marrow, which is important for understanding how well the treatment is working.
Methodology
112 bone marrow aspirates from 30 chemo-naïve patients were stained using anti-NCAM antibodies at diagnosis and after chemotherapy.
Participant Demographics
30 chemo-naïve patients with small-cell lung cancer.
Statistical Information
P-Value
0.002
Statistical Significance
p=0.002
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website